1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction
2.1 Dermal Filler Overview

3 Products under Development
3.1 Dermal Filler - Pipeline Products by Stage of Development
3.2 Dermal Filler - Pipeline Products by Territory
3.3 Dermal Filler - Pipeline Products by Regulatory Path
3.4 Dermal Filler - Pipeline Products by Estimated Approval Date
3.5 Dermal Filler - Ongoing Clinical Trials

4 Dermal Filler - Pipeline Products under Development by Companies
4.1 Dermal Filler Companies - Pipeline Products by Stage of Development
4.2 Dermal Filler - Pipeline Products by Stage of Development

5 Dermal Filler Companies and Product Overview
5.1 Aeon Astron Corporation Company Overview
5.2 Allergan Plc Company Overview
5.3 Almirall Ltd Company Overview
5.4 Bioxis Pharmaceuticals Company Overview
5.5 BMG Pharma srl Company Overview
5.6 Bmi Korea Co Ltd Company Overview
5.7 Celltrix AB Company Overview
5.8 CollPlant Holdings Ltd Company Overview
5.9 EternoGen Aesthetics LLC Company Overview
5.10 Genzyme Corp Company Overview
5.11 Innovia LLC Company Overview
5.12 Juvenis Ltd Company Overview
5.13 Khorionyx SA Company Overview
5.14 Medy-Tox Inc Company Overview
5.15 Mesoestetic Pharma Group SL Company Overview
5.16 Moma Therapeutics, Inc. Company Overview
5.17 N8 Medical Inc Company Overview
5.18 Oligo Medic Inc Company Overview
5.19 PB&B SA Company Overview
5.20 PetVivo Holdings Inc Company Overview
5.21 Regenscientific Company Overview
5.22 Samyang Biopharmaceuticals Corp Company Overview
5.23 Sebana Medical Ltd Company Overview
5.24 Sekisui Medical Co Ltd Company Overview
5.25 Shanghai Haohai Biological Technology Co Ltd Company Overview
5.26 Shin Poong PharmCo Ltd Company Overview
5.27 Sinclair Pharma PLC Company Overview
5.28 Sofregen Medical Inc Company Overview
5.29 TEI Biosciences Inc Company Overview
5.30 University of California Santa Barbara Company Overview

6 Dermal Filler- Recent Developments
6.1 Jul 19, 2018: Suneva Medical promotes Patricia Altavilla to chief operating officer
6.2 Jul 05, 2018: Sinclair Pharma: Trading Update for the 6 months to 30 June 2018
6.3 Jun 04, 2018: SWAG Penis Enhancement Procedure Developed by Top Plastic Surgeon Achieving Optimal Results
6.4 May 21, 2018: Nestle Skin Health Announces the FDA Approval of Restylane Lyft for Hands, the First and Only Hyaluronic Acid (HA) Dermal Filler for Use in the Back of Hands
6.5 May 15, 2018: BTG: Final Results For year ended 31 March 2018
6.6 May 09, 2018: FibroGen Reports First Quarter 2018 Financial Results
6.7 May 08, 2018: Smith & Nephew: Change of Directorate
6.8 May 08, 2018: CollPlant Files U.S. Patent Application for Next Generation Dermal Filler
6.9 May 03, 2018: Smith & Nephew First Quarter 2018 Trading Report
6.10 May 02, 2018: Anika Reports First Quarter 2018 Financial Results
6.11 Apr 30, 2018: Sinclair Pharma: Preliminary results for 12 months ended 31 December 2017
6.12 Apr 30, 2018: Sinclair secures €23 million debt facility
6.13 Apr 09, 2018: Merz Aesthetics Launches New Belotero Lips Dermal Filler Products
6.14 Apr 04, 2018: Namal Nawana appointed Chief Executive Officer of Smith & Nephew
6.15 Mar 20, 2018: Governor Abbott Announces Smith & Nephew Adding New Jobs In Fort Worth
6.16 Mar 05, 2018: Anika Therapeutics Names Joseph Darling As CEO And Director
6.17 Mar 01, 2018: Smith & Nephew: Change in Directorate
6.18 Feb 27, 2018: FibroGen Announces Fourth Quarter and Full Year 2017 Financial Results
6.19 Feb 21, 2018: Anika Announces Fourth Quarter and Full Year 2017 Financial Results
6.20 Feb 16, 2018: Merz North America to Highlight Treatments at American Academy of Dermatology Annual Meeting
6.21 Feb 08, 2018: Smith & Nephew Fourth Quarter Trading and Full Year 2017 Results
6.22 Jan 31, 2018: Smith & Nephew Appoints Roland Diggelmann As Non-Executive Director
6.23 Jan 31, 2018: Appointment of Roland Diggelmann as Non-Executive Director
6.24 Jan 16, 2018: Galderma Introduces Restylane Skinboosters
6.25 Jan 16, 2018: Sinclair Pharma: Ellanse Approved for Brazil

7 Appendix
7.1 Methodology
7.2 About GlobalData
7.3 Contact Us
7.4 Disclaimer

1.1 List of Tables
Table 1: Dermal Filler - Pipeline Products by Stage of Development
Table 2: Dermal Filler - Pipeline Products by Territory
Table 3: Dermal Filler - Pipeline Products by Regulatory Path
Table 4: Dermal Filler - Pipeline Products by Estimated Approval Date
Table 5: Dermal Filler - Ongoing Clinical Trials
Table 6: Dermal Filler Companies - Pipeline Products by Stage of Development
Table 7: Dermal Filler - Pipeline Products by Stage of Development
Table 8: Aeon Astron Corporation Pipeline Products & Ongoing Clinical Trials Overview
Table 9: BioDermal Filler - Product Status
Table 10: BioDermal Filler - Product Description
Table 11: Allergan Plc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: HA Threads - Product Status
Table 13: HA Threads - Product Description
Table 14: JUVEDERM Volbella - Tear Trough - Product Status
Table 15: JUVEDERM Volbella - Tear Trough - Product Description
Table 16: Juvederm Vollure XC - Product Status
Table 17: Juvederm Vollure XC - Product Description
Table 18: JUVEDERM VOLUMA - Nose - Product Status
Table 19: JUVEDERM VOLUMA - Nose - Product Description
Table 20: JUVEDERM Voluma Global - Malar Augmentation - Product Status
Table 21: JUVEDERM Voluma Global - Malar Augmentation - Product Description
Table 22: VYC-25L Hyaluronic Acid Injectable Gel - Product Status
Table 23: VYC-25L Hyaluronic Acid Injectable Gel - Product Description
Table 24: Almirall Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 25: Hyaluronic Acid Facial Filler - Product Status
Table 26: Hyaluronic Acid Facial Filler - Product Description
Table 27: Bioxis Pharmaceuticals Pipeline Products & Ongoing Clinical Trials Overview
Table 28: CYTOSIAL Deep Wrinkle - Product Status
Table 29: CYTOSIAL Deep Wrinkle - Product Description
Table 30: CYTOSIAL Medium - Product Status
Table 31: CYTOSIAL Medium - Product Description
Table 32: Cytosial Volume - Product Status
Table 33: Cytosial Volume - Product Description
Table 34: Cytosmile - Product Status
Table 35: Cytosmile - Product Description
Table 36: MTI-12 - Surgical Repair - Product Status
Table 37: MTI-12 - Surgical Repair - Product Description
Table 38: BMG Pharma srl Pipeline Products & Ongoing Clinical Trials Overview
Table 39: SGA300 - Product Status
Table 40: SGA300 - Product Description
Table 41: SGA302 - Product Status
Table 42: SGA302 - Product Description
Table 43: Bmi Korea Co Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 44: BMI4002 - Product Status
Table 45: BMI4002 - Product Description
Table 46: Celltrix AB Pipeline Products & Ongoing Clinical Trials Overview
Table 47: Credurance - Product Status
Table 48: Credurance - Product Description
Table 49: CollPlant Holdings Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Next Generation Dermal Filler - Product Status
Table 51: Next Generation Dermal Filler - Product Description
Table 52: EternoGen Aesthetics LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Cellifique - Product Status
Table 54: Cellifique - Product Description
Table 55: Genzyme Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 56: PREVELLE Lift - Product Status
Table 57: PREVELLE Lift - Product Description
Table 58: Innovia LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Wrinkle Filler - Product Status
Table 60: Wrinkle Filler - Product Description
Table 61: Juvenis Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Tenergel - Product Status
Table 63: Tenergel - Product Description
Table 64: Khorionyx SA Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Autologous Globin Dermal Filler - Product Status
Table 66: Autologous Globin Dermal Filler - Product Description
Table 67: Medy-Tox Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 68: MT943 - Product Status
Table 69: MT943 - Product Description
Table 70: Neuramis Deep Lidocaine - Product Status
Table 71: Neuramis Deep Lidocaine - Product Description
Table 72: Neuramis Volume Lidocaine - Product Status
Table 73: Neuramis Volume Lidocaine - Product Description
Table 74: Medy-Tox Inc - Ongoing Clinical Trials Overview
Table 75: Neuramis Volume Lidocaine - Clinical Study of Neuramis Volume Lidocaine to Evaluate the Efficacy and Safety for Temporary Restoring the Mid-face Volume
Table 76: Mesoestetic Pharma Group SL Pipeline Products & Ongoing Clinical Trials Overview
Table 77: mRDX-02-17 - Product Status
Table 78: mRDX-02-17 - Product Description
Table 79: Mesoestetic Pharma Group SL - Ongoing Clinical Trials Overview
Table 80: mRDX-02-17 - A Multicentre, Open-label, Interventional, Pilot Trial to Assess the Performance and Tolerance of mRDX-02-17 Dermal Filler in the Facial Rejuvenation

1.2 List of Figures
Figure 1: Dermal Filler - Pipeline Products by Stage of Development
Figure 2: Dermal Filler - Pipeline Products by Territory
Figure 3: Dermal Filler - Pipeline Products by Regulatory Path
Figure 4: Dermal Filler - Pipeline Products by Estimated Approval Date
Figure 5: Dermal Filler - Ongoing Clinical Trials

Companies Mentioned
- Aeon Astron Corporation
- Allergan Plc
- Almirall Ltd
- Bioxis Pharmaceuticals
- BMG Pharma srl
- Bmi Korea Co Ltd
- Celltrix AB
- CollPlant Holdings Ltd
- EternoGen Aesthetics LLC
- Genzyme Corp
- Innovia LLC
- Juvenis Ltd
- Khorionyx SA
- Medy-Tox Inc
- Mesoestetic Pharma Group SL
- Moma Therapeutics, Inc.
- N8 Medical Inc
- Oligo Medic Inc
- PB&B SA
- PetVivo Holdings Inc
- Regenscientific
- Samyang Biopharmaceuticals Corp
- Sebana Medical Ltd
- Sekisui Medical Co Ltd
- Shanghai Haohai Biological Technology Co Ltd
- Shin Poong PharmCo Ltd
- Sinclair Pharma PLC
- Sofregen Medical Inc
- TEI Biosciences Inc
- University of California Santa Barbara